Mikart LLC, a Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of small molecules, has enhanced its manufacturing capabilities with the addition of nitrogen-purged liquid and suspension suites.
 
The upgraded facilities are now fully equipped to manufacture and package liquid products under nitrogen, providing a controlled environment that prevents oxidation and degradation. This advancement is crucial for clients whose liquid products are particularly sensitive to these conditions.
 
“By integrating nitrogen-purged technology into our liquid and suspension suites, we can better serve our clients by ensuring the integrity and longevity of their products,” said Nazar Elkarim, VP, Product Development Services at Mikart. “This enhancement aligns with our commitment to innovation and quality, enabling us to meet the evolving needs of the pharmaceutical industry.”
 
Mikart’s nitrogen-purged suites are designed to handle liquid and suspension products, maintaining optimal conditions throughout the manufacturing and packaging processes. This ensures that active ingredients remain stable and effective, ultimately leading to safer and more reliable products for end-users.
 
The implementation of nitrogen-purged suites is just one of the many ways Mikart continues to enhance its capabilities and uphold its reputation as a trusted partner in the pharmaceutical manufacturing sector.